Gene Therapy Trials Could Be Halted If Public Disclosure Is Not Made - FDA
Executive Summary
FDA's gene therapy disclosure proposal would permit the agency to impose a clinical hold on trials if a sponsor fails to submit a redacted version of information for public disclosure.